An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Bicara Therapeutics in Boston is seeking a proactive Senior Manager, Accounting and SEC Reporting to lead the preparation of Form 10-K and 10-Q, manage G&A accruals, and oversee stock compensation accounting under ASC 718. This hands-on role reports to the Senior Director, Accounting and requires collaboration with legal, IR, and finance teams to ensure timely, compliant reporting and SOX controls.
Hybrid schedule with three in-office days per week; the ideal candidate will bring 8+ years of US
Bicara Therapeutics is seeking a proactive and detail-oriented Senior Manager, Accounting and SEC Reporting, to join our growing Accounting Team. This individual will report to the Senior Director, Accounting and will be responsible for preparation of all SEC reporting documents including Form 10K and 10Q. This position will also be responsible for preparing and managing G&A accruals, for performing all activities related to company’s stock compensation expenses and for working both independently and as part of a team to support Bicara's launch compliance with Sarbanes-Oxley Act requirements. This is a hands‑on position and the ability to multitask and work with others is essential.
This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.
Bicara Therapeutics is a clinical‑stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first‑in‑class bifunctional EGFR‑directed antibody combined with a TGF‑β ligand trap. Our innovative approach combines tumor‑targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF‑β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com.
Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.
Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.